“ Clinical and Economic Aspects of the Use of Rituximab in Non-Hodgkin’s Lymphoma ”. Brazilian Journal of Pharmaceutical Sciences 50, no. 3 (September 1, 2014): 445–455. Accessed May 13, 2024. https://revistas.usp.br/bjps/article/view/87931.